Importantly, in the present study, we discovered a significant growth inhibition of adenoid cystic carcinoma cells following downregulation of ADAM10 via ADAM 10-specific siRNA, which suggested that ADAM 10 is a promising new therapeutic target for the treatment of adenoid cystic carcinoma. The gene discussed is ADAM10; the disease is adenoid cystic carcinoma.